In order to overcome illness, there are three important conditions.
・The most important thing is for the patient to strongly desire to get well.
・Secondly, that there is the warm support of the family.
・Finally, there needs to be adequate support from medical practitioners.
My own mentor first taught me this when I became a doctor. Since that time, I have always aimed to provide care that is respectful, easy-to-understand, and supportive to the patient.
Cancer immune cell therapy is a field undergoing remarkable progress. We continue to make every effort to improve patient care by updating the patient and their families with the latest knowledge and providing the best medical care.
Born in Nagoya. Raised in Canada, and Fukui.
Doctor of Medicine, Certified Specialist of the Japanese Society of Hematology Society, Certified General Internal Medicine Specialist of the Japanese Society of Internal Medicine, Certified Internist of the Japanese Society of Internal Medicine, Certified Industrial Physician of the Japan Medical Association.
|1998||Graduated from Fukui University School of Medicine|
|2006||Graduated from Kyoto University Graduate School of Medicine|
|1998||Department of Internal Medicine, Kyoto University Hospital|
|1999||Department of Internal Medicine, Kishiwada City Hospital (Osaka)|
|2001||Graduate School of Medicine, Kyoto University, Department of Hematology and Oncology. Involved in research on Human T-lymphotropic virus (HTLV-1). Obtained Doctorate in Medicine in 2006.|
|2006||Sugita Genpaku Memorial Obama Municipal Hospital (Fukui Prefecture) Department of Internal Medicine|
|2007||University of Alabama at Birmingham, Pathology Department, Postdoctoral Fellow|
|2008||National Institute of Health, National Cancer Institute, Postdoctoral Fellow. Involved in research on leukemia and solid cancer oncogenes and signal transduction.|
|2010||Tokyo Medical and Dental University, Department of Immunotherapeutics, Assistant Professor. Involved in basic research and clinical research on dendritic cell immunotherapy for adult T cell leukemia (ATL).|
|2013||Tokyo Cancer Clinic|
|2014||Director, Tokyo Cancer Clinic|
- Academic society affiliations
- Japanese Society of Hematology, Japanese Society of Medical Oncology, Japanese Cancer Association, the Japanese Society of Internal Medicine, International Society of Personalized Medicine, Society of Immunotherapy for Hematological Disorders.